by Ellie Lampton | Apr 28, 2026
New AI-powered experience removes the time-to-evidence barrier, enabling healthcare leaders to better understand and make informed decisions based on what’s happening in care today BELLEVUE, Wash.—April 28, 2026— Truveta today announced Truveta Intelligence, a new...
by Ellie Lampton | Mar 31, 2026
Providence President and CEO brings extensive experience advancing innovation, operations, and patient-centered care at scale. BELLEVUE, Wash.— March 31, 2026—Grounded in its mission of Saving Lives with Data, Truveta today announced the appointment of Erik Wexler,...
by Ellie Lampton | Mar 31, 2026
Veteran healthcare finance executive brings decades of experience advancing disciplined value creation. BELLEVUE, Wash.— March 31, 2026—Grounded in its mission of Saving Lives with Data, Truveta today announced that Robin Damschroder, FACHE, Executive Vice President,...
by Ellie Lampton | Feb 10, 2026
BELLEVUE, Wash.—February 10, 2026—A new peer-reviewed study led by Truveta Research and collaborators finds that the US Food and Drug Administration’s (FDA) March 2024 expansion of semaglutide’s cardiovascular indication was followed by a rapid but short-lived...
by Ellie Lampton | Feb 9, 2026
Globally recognized pharmacoepidemiologist brings decades of experience advancing real-world evidence for regulatory decision-making. BELLEVUE, Wash.—February 9, 2026—Truveta today announced the appointment of John D. Seeger, PharmD, DrPH, FISPE, a global leader in...
